Pursuant to SEBI Circular No: SEBI/HO/MIRSD/DOP1/CIR/P/2018/73 dated 20th April, 2018 & BSE circular LIST/COMP/15/2018-19 dated 5th July, 2018 informing the Amendment in Regulation 40 Of SEBI (LODR) Regulation, 2015; Dr Habeerbullah Life Sciences has informed that the Registrar & Share Transfer Agent Venture Capital and Corporate Investments has dispatched the letter to the shareholders relating to 1st KYC reminder and mandatory dematerialization for transfer of shares.
The above information is a part of company’s filings submitted to BSE.